Biotechnology
Sort by: Featured Most recent Most read Most commented
75 results total, viewing 21 - 30
Covidien earnings rise to $1.9B in 2012
Medical technology maker Covidien PLC reported fourth-quarter earnings of $461 million, or 95 cents per diluted share, a rise of 2.2 percent from the $451 million, or 92 cents per diluted share reported during the same period in 2011. more
| 11/12/12
FDA scrutinizes Covidien over surgical staple recall
Medical device maker Covidien PLC is facing scrutiny from the U.S. Food and Drug Administration over the way its management handled the recall of its Duet TRS surgical staples. more
| 6/28/12
Covidien lands added FDA approval for LigaSure
Covidien PLC has received 510(k) clearance from the U.S. Food and Drug Administration to use its LigaSure curved, small jaw, open sealer/divider in ear, nose and throat procedures. more
| 9/11/12
Covidien’s Mallinckrodt lands FDA approval for ADHD drug
Mallinckrodt, the pharmaceuticals business of biotechnology giant Covidien PLC, has received approval from the U.S. Food and Drug Administration to manufacture and market a generic version of its Concerta tablets for the treatment of attention deficit hyperactivity disorder, the company announced Monday. more
| 12/31/12
EpiVax awarded $55,000 to explore nerve disease treatment
Providence-based EpiVax Inc. was awarded a $55,000 grant from the GBS/CIDP Foundation International to explore using Tregitopes as a new therapy for a nerve disease that is treated currently with intravenous immunoglobulin. more
Amgen sales rise to $4.2B in 3Q
Thousand Oaks, Calif.–based Amgen, one of the world’s largest biotechnology companies, saw revenue rise 9.5 percent to $4.3 billion in the three months ended Sept. 30 from $3.9 billion during the same period in 2011. more
| 10/24/12
Nabsys lands $20M in Series D round
Nabsys Inc., a life sciences company focused on the creation of a single-molecule platform for genomic analysis, has closed a $20 million Series D financing round, the company announced Wednesday. more
UMass Dartmouth completes first stage of MAB construction
Seven months after the initial groundbreaking, the University of Massachusetts Dartmouth celebrated the end of the first stage of construction of the Massachusetts Accelerator for Biomanufacturing with a “topping off ceremony” on Thursday in Fall River. more
| 12/7/12
Lucidux lands $250K from Slater fund
Medical imaging innovator Lucidux LLC has landed a $250,000 investment from public venture capital firm Slater Technology Fund. more
Amgen places bet on heart drug as rivals go after sales
Amgen Inc., the world’s largest biotechnology company, is developing a new anti-cholesterol medicine by 2015 that it sees as its best shot to offset reduced sales when its popular anemia drugs lose exclusivity. more
« Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 … 8 | Next »
Calendar
PBN Hosted
Events

Celebrate RI's many exceptional women at PBN's Business Women Awards luncheon May 30th at the Providence Marriott. Reserve your seat today!
Advertisement
National
Local
Latest News